🇺🇸 FDA

Intelligence · Clinical Pipeline

R&D Pipeline Programs

ClinicalTrials.gov programs linked to pharma sponsors — phase, modality, and trial IDs for BD and competitive intelligence.

Programs indexed
18,156
Companies
1,062
Drugs tracked
3,385

Quick answer

NovaPharmaNews tracks 18,156 pharmaceutical R&D pipeline programs sourced from ClinicalTrials.gov, linked to sponsor companies. Each profile includes development phase, modality, trial status, NCT identifiers, and indication text — searchable for business development and competitive intelligence.

102 results for “Vor” Clear

  1. Bioequivalence clinical trial of two formulations of vortioxetine.

    Laboratorios Tillomed Spain S.L.U

    Healthy volunteers

    phase 1 other active

    1 trial

  2. Bioequivalence of Vortioxetine 20 mg Film-Coated Tablets in Healthy Participants Under Fasting Conditions

    Laboratorios Tillomed Spain S.L.U

    No medical condition

    phase 1 other active

    1 trial

  3. Bioequivalence of Vortioxetine 5 mg Film-Coated Tablets in Healthy Participants Under Fasting Conditions.

    Laboratorios Tillomed Spain S.L.U

    No medical condition.

    phase 1 other active

    1 trial

  4. Chinese tea flavor liquor

    China SXT Pharmaceuticals

    Alcohols

    phase 1 other completed

    1 trial

  5. Danavorexton

    Takeda Pharmaceuticals International AG

    Healthy Volunteers

    phase 1 small molecule completed

    1 trial

  6. Evorpacept

    ALX ONCOLOGY HOLDINGS INC

    Bladder Cancer

    phase 1 small molecule completed

    1 trial

  7. Evorpacept (ALX148)

    ALX ONCOLOGY HOLDINGS INC

    Metastatic Cancer

    phase 1 small molecule completed

    1 trial

  8. Mavorixafor

    X4 Pharmaceuticals, Inc

    Waldenstrom's Macroglobulinemia

    phase 1 small molecule completed

    1 trial

  9. Mavorixafor

    X4 Pharmaceuticals, Inc

    Healthy Participants

    phase 1 small molecule completed

    1 trial

  10. Mavorixafor

    X4 Pharmaceuticals, Inc

    Hepatic Insufficiency

    phase 1 small molecule active

    1 trial

  11. Randomised, crossover bioequivalence clinical trial of vortioxetine 20 mg film-coated tablets, after a single oral dose administration to healthy volunteers under fasting conditions.

    Laboratorios Tillomed Spain S.L.U

    Antidepressant

    phase 1 other active

    1 trial

  12. Voriconazole 200mg

    First Tracks Biotherapeutics

    Cryptococcal Meningitis

    phase 1 small molecule active

    1 trial

  13. Vortioxetine

    Takeda Pharmaceuticals International AG

    Healthy Adult Participants

    phase 1 small molecule completed

    1 trial

  14. Vortioxetine

    Takeda Pharmaceuticals International AG

    Healthy

    phase 1 small molecule completed

    1 trial

  15. Vortioxetine

    Takeda Pharmaceuticals International AG

    Severe Hepatic Impairment

    phase 1 small molecule completed

    1 trial

  16. avoralstat

    Biocryst

    Diabetic Macular Edema (DME)

    phase 1 small molecule terminated

    1 trial

  17. evorpacept

    ALX ONCOLOGY HOLDINGS INC

    Acute Myeloid Leukemia

    phase 1 small molecule terminated

    1 trial

  18. evorpacept

    ALX ONCOLOGY HOLDINGS INC

    Higher Risk Myelodysplastic Syndromes

    phase 1 small molecule terminated

    1 trial

  19. Leucovorin calcium

    Ultragenyx UK Limited

    Toxoplasmosis

    approved small molecule active

    1 trial

  20. Medtronic Endeavor Resolute

    Rhythm Pharmaceuticals Netherlands B.V.

    Coronary Artery Disease

    approved other completed

    1 trial

  21. PROPESS 10 mg, système de diffusion vaginal, PROSTINE E2 2 mg/3 g, gel vaginal, ANGUSTA 25 microgrammes, comprime, OXYTOCINE PANPHARMA 5 UI/1 ml, solution injectable

    Tour Hekla

    Labor Induction of women with an unfavorable Cervix after 24 hours of cervical ripening

    approved small molecule active

    1 trial

  22. Vortioxetine

    Takeda Pharmaceuticals International AG

    Major Depressive Disorder

    approved small molecule completed

    9 trials

  23. Vortioxetine

    Takeda Pharmaceuticals International AG

    Healthy Volunteers

    approved small molecule completed

    1 trial

  24. Vortioxetine

    Takeda Pharmaceuticals International AG

    Schizophrenia

    approved small molecule active

    1 trial

Frequently asked questions

What is the NovaPharmaNews pipeline directory?

It is a searchable index of 18,156 clinical development programs grouped by sponsor company, with phase (Phase 1–3), modality, trial status, and linked NCT IDs from ClinicalTrials.gov.

Where does pipeline data come from?

Program records are derived from ClinicalTrials.gov and linked to NovaPharmaNews company profiles. Trial status and phase reflect registry data at last sync — verify on ClinicalTrials.gov before investment or partnering decisions. See our data sources page for attribution.

How do I find pipeline programs by company or phase?

Use the search box to match program name, indication, company name, or slug. Results are ordered with late-stage (Phase 3) programs first. Open any row to view the full program profile under its sponsor company.

Data attribution and licensing: Data sources